REG3G
gene geneOn this page
Also known as UNQ429LPPM429PAP1B
Summary
REG3G (regenerating family member 3 gamma, HGNC:29595) is a protein-coding gene on chromosome 2p12, encoding Regenerating islet-derived protein 3-gamma (Q6UW15). Bactericidal C-type lectin which acts exclusively against Gram-positive bacteria and mediates bacterial killing by binding to surface-exposed carbohydrate moieties of peptidoglycan.
This gene encodes a member of the regenerating islet-derived genes (REG)3 protein family. These proteins are secreted, C-type lectins with a carbohydrate recognition domain and N-terminal signal peptide. The protein encoded by this gene is an antimicrobial lectin with activity against Gram-positive bacteria. Alternative splicing results in multiple transcript variants encoding multiple isoforms.
Source: NCBI Gene 130120 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 44 total
- MANE Select transcript:
NM_001008387
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29595 |
| Approved symbol | REG3G |
| Name | regenerating family member 3 gamma |
| Location | 2p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | UNQ429, LPPM429, PAP1B |
| Ensembl gene | ENSG00000143954 |
| Ensembl biotype | protein_coding |
| OMIM | 609933 |
| Entrez | 130120 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 retained_intron
ENST00000272324, ENST00000393897, ENST00000409471, ENST00000490944, ENST00000498312, ENST00000870567, ENST00000944248
RefSeq mRNA: 3 — MANE Select: NM_001008387
NM_001008387, NM_001270040, NM_198448
CCDS: CCDS1962, CCDS58714
Canonical transcript exons
ENST00000272324 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001827400 | 79025702 | 79025773 |
| ENSE00001929546 | 79028209 | 79028501 |
| ENSE00002479283 | 79027034 | 79027171 |
| ENSE00002521085 | 79027807 | 79027933 |
| ENSE00002524356 | 79026713 | 79026831 |
| ENSE00003615632 | 79025983 | 79026169 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 99.35.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3607 / max 210.2737, expressed in 9 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21125 | 0.1477 | 6 |
| 21127 | 0.0900 | 8 |
| 21126 | 0.0667 | 8 |
| 21124 | 0.0564 | 6 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.35 | gold quality |
| pancreas | UBERON:0001264 | 96.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.81 | gold quality |
| right testis | UBERON:0004534 | 91.53 | gold quality |
| left testis | UBERON:0004533 | 90.51 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.54 | gold quality |
| testis | UBERON:0000473 | 88.63 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.80 | gold quality |
| left adrenal gland | UBERON:0001234 | 87.74 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 85.88 | gold quality |
| adrenal cortex | UBERON:0001235 | 84.79 | gold quality |
| pancreatic ductal cell | CL:0002079 | 83.52 | gold quality |
| ileal mucosa | UBERON:0000331 | 81.82 | gold quality |
| adrenal gland | UBERON:0002369 | 79.81 | gold quality |
| cauda epididymis | UBERON:0004360 | 77.93 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 76.80 | gold quality |
| corpus epididymis | UBERON:0004359 | 76.64 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 74.42 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 73.91 | gold quality |
| small intestine | UBERON:0002108 | 73.90 | gold quality |
| oocyte | CL:0000023 | 72.53 | gold quality |
| upper arm skin | UBERON:0004263 | 69.08 | gold quality |
| duodenum | UBERON:0002114 | 68.40 | gold quality |
| pons | UBERON:0000988 | 67.65 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 66.70 | gold quality |
| body of tongue | UBERON:0011876 | 66.48 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.42 | gold quality |
| parotid gland | UBERON:0001831 | 65.21 | gold quality |
| tibialis anterior | UBERON:0001385 | 65.10 | silver quality |
| thymus | UBERON:0002370 | 65.02 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-81547 | yes | 5612.55 |
| E-ANND-3 | yes | 19.34 |
| E-MTAB-5061 | yes | 19.00 |
| E-ENAD-27 | yes | 6.99 |
| E-HCAD-31 | yes | 4.07 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AR, FOXA2
miRNA regulators (miRDB)
49 targeting REG3G, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
Literature-anchored findings (GeneRIF, showing 7)
- REG III was identified and expressed predominantly in pancreas and testis, but not in small intestine (PMID:15556304)
- PAP IB represents a good example of duplication and divergence, probably with the acquisition of new functions, thus participating in the evolution of the protein repertoire. (PMID:15777617)
- This gene encodes a secreted peptide that displays antimicrobial activity against Gram-positive bacteria. (PMID:16931762)
- a model of CagA-directed REG3gamma expression in gastric epithelial cells via activation of the IL-11/gp130/STAT3 pathway (PMID:22312430)
- Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis. (PMID:31767934)
- Role of oncogenic REGgamma in cancer. (PMID:32935661)
- Myocardial Accumulations of Reg3A, Reg3gamma and Oncostatin M Are Associated with the Formation of Granulomata in Patients with Cardiac Sarcoidosis. (PMID:33923774)
Cross-species orthologs
19 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-125e6.11 | ENSDARG00000025783 |
| danio_rerio | zgc:172053 | ENSDARG00000038321 |
| danio_rerio | si:dkey-241l7.6 | ENSDARG00000041248 |
| danio_rerio | si:dkey-9i23.4 | ENSDARG00000051993 |
| danio_rerio | lectin | ENSDARG00000055833 |
| danio_rerio | si:ch211-125e6.5 | ENSDARG00000069381 |
| danio_rerio | si:dkey-241l7.3 | ENSDARG00000086956 |
| danio_rerio | si:dkey-241l7.5 | ENSDARG00000088989 |
| danio_rerio | si:dkey-241l7.4 | ENSDARG00000089478 |
| danio_rerio | si:ch211-125e6.12 | ENSDARG00000092090 |
| danio_rerio | si:dkey-9i23.5 | ENSDARG00000092459 |
| danio_rerio | si:ch211-125e6.14 | ENSDARG00000094183 |
| danio_rerio | si:ch211-125e6.13 | ENSDARG00000094370 |
| danio_rerio | si:dkey-241l7.2 | ENSDARG00000105335 |
| caenorhabditis_elegans | WBGENE00012621 | |
| caenorhabditis_elegans | WBGENE00016912 | |
| caenorhabditis_elegans | WBGENE00019328 | |
| caenorhabditis_elegans | WBGENE00019914 | |
| caenorhabditis_elegans | WBGENE00020585 |
Paralogs (5): REG1A (ENSG00000115386), REG4 (ENSG00000134193), REG3A (ENSG00000172016), REG1B (ENSG00000172023), CLEC19A (ENSG00000261210)
Protein
Protein identifiers
Regenerating islet-derived protein 3-gamma — Q6UW15 (reviewed: Q6UW15)
Alternative names: Pancreatitis-associated protein 1B, Pancreatitis-associated protein IB, Regenerating islet-derived protein III-gamma
All UniProt accessions (1): Q6UW15
UniProt curated annotations — full annotation on UniProt →
Function. Bactericidal C-type lectin which acts exclusively against Gram-positive bacteria and mediates bacterial killing by binding to surface-exposed carbohydrate moieties of peptidoglycan. Restricts bacterial colonization of the intestinal epithelial surface and consequently limits activation of adaptive immune responses by the microbiota. Acts as a hormone in response to different stimuli like anti-inflammatory signals, such as IL17A, or gut microbiome. Is secreted by different cell types to activate its receptor EXTL3 and induce cell specific signaling pathways. Induced by IL17A in keratinocytes, regulates keratinocyte proliferation and differentiation after skin injury. In parallel, inhibits skin inflammation through the inhibition of inflammatory cytokines such as IL6 and TNF. Induced by IL22 in lung epithelial cells, inhibits cytokine production and regulates allergic airway inflammation. Induced in small intestine by inulin-enriched diet and Lactobacillus gasseri enriched microbiome, plays a role in the improvement of gut barrier function, the regulation of energy balance and glucose levels. Modulates microbiota composition in duodenal contents. Produced by nociceptor in response to endotoxins, prevents endotoxic death by targeting kynurenine pathway in microglia. Has bacteriostatic activity. Has bactericidal activity against L.monocytogenes and methicillin-resistant S.aureus.
Subunit / interactions. Forms a hexameric membrane-permeabilizing oligomeric pore on membrane phospholipids. The hexamer is formed by three dimers related by helical symmetry. Forms filaments, filamentation traps pore complexes and limits damage to host cells. Interacts with EXTL3.
Subcellular location. Secreted. Cytoplasm.
Tissue specificity. Predominantly expressed in pancreas, where it may be restricted to exocrine pancreas. Moderate expression levels in testis and weak in heart, kidney and placenta.
Post-translational modifications. Proteolytic processing by trypsin removes an inhibitory N-terminal propeptide and is essential for peptidoglycan binding and antibacterial activity.
Activity regulation. Lipopolysaccharide inhibits pore-forming activity, explaining why is bactericidal for Gram-positive but not Gram-negative bacteria.
Domain organisation. The EPN motif is essential for recognition of the peptidoglycan carbohydrate backbone and for efficient bacterial killing with Glu-114 playing a key role in peptidoglycan binding and bactericidal activity.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UW15-1 | 1 | yes |
| Q6UW15-2 | 2 |
RefSeq proteins (3): NP_001008388, NP_001256969, NP_940850 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001304 | C-type_lectin-like | Domain |
| IPR016186 | C-type_lectin-like/link_sf | Homologous_superfamily |
| IPR016187 | CTDL_fold | Homologous_superfamily |
| IPR018378 | C-type_lectin_CS | Conserved_site |
| IPR050111 | C-type_lectin/snaclec_domain | Family |
Pfam: PF00059
UniProt features (15 total): disulfide bond 3, binding site 3, chain 2, signal peptide 1, splice variant 1, sequence conflict 1, propeptide 1, domain 1, region of interest 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UW15-F1 | 89.50 | 0.77 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 107; 121; 145
Disulfide bonds (3): 40–51, 68–171, 146–163
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6803157 | Antimicrobial peptides |
MSigDB gene sets: 123 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_EPITHELIUM_DEVELOPMENT, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, GOBP_REGULATION_OF_WOUND_HEALING, GOBP_INFLAMMATORY_RESPONSE, GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT, GOBP_KERATINOCYTE_PROLIFERATION, GOMF_GROWTH_FACTOR_ACTIVITY, GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY, GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION, GOBP_WOUND_HEALING, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS
GO Biological Process (10): MyD88-dependent toll-like receptor signaling pathway (GO:0002755), acute-phase response (GO:0006953), positive regulation of cell population proliferation (GO:0008284), positive regulation of keratinocyte proliferation (GO:0010838), response to peptide hormone (GO:0043434), negative regulation of keratinocyte differentiation (GO:0045617), defense response to Gram-positive bacterium (GO:0050830), antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844), positive regulation of wound healing (GO:0090303), inflammatory response (GO:0006954)
GO Molecular Function (5): signaling receptor activity (GO:0038023), peptidoglycan binding (GO:0042834), metal ion binding (GO:0046872), oligosaccharide binding (GO:0070492), carbohydrate binding (GO:0030246)
GO Cellular Component (3): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| toll-like receptor signaling pathway | 1 |
| acute inflammatory response | 1 |
| cell population proliferation | 1 |
| regulation of cell population proliferation | 1 |
| positive regulation of cellular process | 1 |
| regulation of keratinocyte proliferation | 1 |
| keratinocyte proliferation | 1 |
| positive regulation of epithelial cell proliferation | 1 |
| response to hormone | 1 |
| response to nitrogen compound | 1 |
| response to oxygen-containing compound | 1 |
| keratinocyte differentiation | 1 |
| negative regulation of epidermal cell differentiation | 1 |
| regulation of keratinocyte differentiation | 1 |
| negative regulation of multicellular organismal process | 1 |
| defense response to bacterium | 1 |
| antimicrobial humoral response | 1 |
| wound healing | 1 |
| regulation of wound healing | 1 |
| positive regulation of response to wounding | 1 |
| defense response | 1 |
| molecular transducer activity | 1 |
| glycosaminoglycan binding | 1 |
| cation binding | 1 |
| carbohydrate binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
850 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| REG3G | IL22 | Q9GZX6 | 864 |
| REG3G | IL22RA2 | Q969J5 | 756 |
| REG3G | MUC1 | P13931 | 625 |
| REG3G | MUC2 | Q02817 | 604 |
| REG3G | IL17A | Q16552 | 598 |
| REG3G | MYD88 | P78397 | 583 |
| REG3G | IL22RA1 | Q8N6P7 | 582 |
| REG3G | NOD2 | Q9HC29 | 574 |
| REG3G | LCN2 | P30150 | 573 |
| REG3G | TLR5 | O60602 | 571 |
| REG3G | OCLN | Q16625 | 541 |
| REG3G | FFAR2 | O15552 | 540 |
| REG3G | IFNG | P01579 | 533 |
| REG3G | IL1B | P01584 | 533 |
| REG3G | S100A7 | P31151 | 528 |
IntAct
0 interactions, top by confidence:
BioGRID (2): REG3G (Negative Genetic), HMGB1P1 (Affinity Capture-MS)
ESM2 similar proteins: A1XXJ9, A3FM55, A7X3Z4, A7X3Z7, A7X413, B4XSY7, B4XSZ1, B4XT00, B4XT01, B4XT02, B4XT03, B4XT08, D1MGU0, E2DQZ6, I7JUQ0, J3S3U6, O09037, O09049, P0DM38, P10758, P23132, P23807, P25031, P35230, P35231, P42854, P43137, Q06141, Q08731, Q09GJ8, Q09GK0, Q38L02, Q5FZI6, Q696W1, Q6T7B5, Q6T7B7, Q6TPH0, Q6UW15, Q71RQ7, Q71RR1
Diamond homologs: A1XXJ9, A3FM55, A7X3W1, A7X3W6, A7X3X0, A7X3X3, A7X3X8, A7X3Y2, A7X3Y6, A7X3Z0, A7X3Z4, A7X3Z7, A7X401, A7X406, A7X409, A7X413, B0VXV0, B0VXV1, B5U6Y6, C6JUN9, D1MGU0, D2YVH7, D2YVI2, D2YVJ6, D2YVJ8, D2YVK1, D2YVK5, D2YW40, D8VNS6, I7ICN3, J3S3U6, J3SBP0, O93427, P05451, P07439, P0DL30, P0DM36, P0DM38, P0DM39, P0DM53
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
585 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:79026706:A:AG | acceptor_gain | 1.0000 |
| 2:79026710:CA:C | acceptor_loss | 1.0000 |
| 2:79026711:A:AG | acceptor_gain | 1.0000 |
| 2:79026711:A:T | acceptor_loss | 1.0000 |
| 2:79026712:G:GG | acceptor_gain | 1.0000 |
| 2:79026712:GGT:G | acceptor_gain | 1.0000 |
| 2:79026772:GCC:G | donor_gain | 1.0000 |
| 2:79026829:GAT:G | donor_gain | 1.0000 |
| 2:79026830:AT:A | donor_gain | 1.0000 |
| 2:79026832:G:GG | donor_gain | 1.0000 |
| 2:79027801:CTATA:C | acceptor_loss | 1.0000 |
| 2:79027802:TATA:T | acceptor_loss | 1.0000 |
| 2:79027803:ATAG:A | acceptor_gain | 1.0000 |
| 2:79027804:TAG:T | acceptor_loss | 1.0000 |
| 2:79027805:A:AC | acceptor_loss | 1.0000 |
| 2:79027805:AG:A | acceptor_gain | 1.0000 |
| 2:79027805:AGG:A | acceptor_gain | 1.0000 |
| 2:79027806:G:T | acceptor_loss | 1.0000 |
| 2:79027806:GG:G | acceptor_gain | 1.0000 |
| 2:79027806:GGG:G | acceptor_gain | 1.0000 |
| 2:79027806:GGGCT:G | acceptor_gain | 1.0000 |
| 2:79026707:C:G | acceptor_gain | 0.9900 |
| 2:79026711:AG:A | acceptor_gain | 0.9900 |
| 2:79026711:AGGT:A | acceptor_gain | 0.9900 |
| 2:79026712:GG:G | acceptor_gain | 0.9900 |
| 2:79026712:GGTG:G | acceptor_gain | 0.9900 |
| 2:79026712:GGTGA:G | acceptor_gain | 0.9900 |
| 2:79026827:CAGAT:C | donor_gain | 0.9900 |
| 2:79026828:AGAT:A | donor_gain | 0.9900 |
| 2:79026829:GATG:G | donor_gain | 0.9900 |
AlphaMissense
1139 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:79027872:G:C | W133C | 0.997 |
| 2:79027872:G:T | W133C | 0.997 |
| 2:79028222:G:C | W158C | 0.997 |
| 2:79028222:G:T | W158C | 0.997 |
| 2:79027839:G:C | W122C | 0.996 |
| 2:79027839:G:T | W122C | 0.996 |
| 2:79027833:G:C | W120C | 0.995 |
| 2:79027833:G:T | W120C | 0.995 |
| 2:79026819:G:C | W61C | 0.994 |
| 2:79026819:G:T | W61C | 0.994 |
| 2:79028220:T:A | W158R | 0.994 |
| 2:79028220:T:C | W158R | 0.994 |
| 2:79027147:G:C | W103C | 0.993 |
| 2:79027147:G:T | W103C | 0.993 |
| 2:79027909:T:A | C146S | 0.992 |
| 2:79027910:G:C | C146S | 0.992 |
| 2:79028259:T:A | C171S | 0.991 |
| 2:79028260:G:C | C171S | 0.991 |
| 2:79028235:T:A | C163S | 0.990 |
| 2:79028236:G:C | C163S | 0.990 |
| 2:79027837:T:A | W122R | 0.989 |
| 2:79027837:T:C | W122R | 0.989 |
| 2:79027040:T:A | C68S | 0.988 |
| 2:79027041:G:C | C68S | 0.988 |
| 2:79026826:G:C | A64P | 0.987 |
| 2:79028236:G:A | C163Y | 0.986 |
| 2:79027041:G:A | C68Y | 0.985 |
| 2:79027910:G:A | C146Y | 0.985 |
| 2:79028211:T:C | F155L | 0.985 |
| 2:79028213:T:A | F155L | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000037572 (2:79024310 G>T), RS1000494503 (2:79027916 G>A), RS1001059705 (2:79024507 C>T), RS1001676543 (2:79025222 A>G), RS1002127277 (2:79025492 A>G), RS1003752544 (2:79026550 T>C), RS1003942032 (2:79026465 T>C), RS1004345022 (2:79028859 T>C), RS1005027812 (2:79024992 C>T), RS1005617018 (2:79027553 A>G), RS1008354073 (2:79023818 T>C), RS1008927885 (2:79025438 T>C), RS1010186021 (2:79024358 C>A), RS1010998646 (2:79025503 AGGGTG>A), RS1011582249 (2:79026925 T>C)
Disease associations
OMIM: gene MIM:609933 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002238_2 | Contrast sensitivity | 1.000000e-07 |
| GCST004575_5 | Acute insulin response | 3.000000e-08 |
| GCST005951_41 | Body mass index | 4.000000e-08 |
| GCST006585_1639 | Blood protein levels | 9.000000e-63 |
| GCST009698_79 | Metabolite levels | 2.000000e-08 |
| GCST012311_29 | Schizophrenia x sex interaction | 5.000000e-06 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005419 | contrast sensitivity measurement |
| EFO:0006831 | acute insulin response measurement |
| EFO:0004340 | body mass index |
| EFO:0010118 | sphingomyelin measurement |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| clothianidin | increases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Isoproterenol | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.